Regeneration Biomedical, Inc. Press Releases

• Published on September 23, 2025 - 16:00 GMT

  

  RBI Advances World’s First Direct-to-Brain Autologous Stem Cell Therapy for Alzheimer’s Into Phase 2 Clinical Trial

  Regeneration Biomedical’s Phase 2 trial of novel direct-to-brain autologous stem cell therapy for Alzheimer’s disease has cleared a 30-day review with the FDA. NEWPORT BEACH, CA, UNITED STATES, September 23, 2025 /⁨EINPresswire.com⁩/ -- Key Takeaways: • …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...
• Published on August 25, 2025 - 16:00 GMT

  Exclusive: Safe, Direct-to-Brain Autologous Stem Cell Therapy Shows Promise in Alzheimer’s

  A Phase 1, "first-in-mankind" trial of stem cells injected directly into the brain, is safe with early signs of efficacy; FDA submission made for Phase 2 trial. NEWPORT BEACH, CA, UNITED STATES, August 25, 2025 /⁨EINPresswire.com⁩/ -- …

  Distribution channels: Healthcare & Pharmaceuticals Industry, Science ...